FBIO Fortress Biotech Inc
Price (delayed)
$1.61
Market cap
$47.55M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.69
Enterprise value
$64.07M
Fortress Biotech, Inc. ("Fortress") is an innovative biopharmaceutical company that was ranked in Deloitte's 2019 and 2020 Technology Fast 500™, annual rankings of the fastest- growing North American companies in
Highlights
Fortress Biotech's EPS has surged by 68% YoY and by 12% QoQ
FBIO's net income is up by 24% YoY and by 5% QoQ
The debt has decreased by 12% YoY but it has increased by 7% QoQ
The gross profit has declined by 40% year-on-year and by 12% since the previous quarter
FBIO's revenue is down by 32% year-on-year and by 8% since the previous quarter
Key stats
What are the main financial stats of FBIO
Market
Valuations
Earnings
Shares outstanding
29.53M
Market cap
$47.55M
Enterprise value
$64.07M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.95
Price to sales (P/S)
0.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.11
Revenue
$57.68M
Gross profit
$36.8M
Operating income
-$110.38M
Net income
-$46M
EBIT
-$32.16M
EBITDA
-$24.85M
Free cash flow
-$80.19M
Per share
Balance sheet
Liquidity
EPS
-$2.69
EPS diluted
-$2.69
Free cash flow per share
-$3.86
Book value per share
$0.82
Revenue per share
$2.77
TBVPS
$5.41
Total assets
$144.22M
Total liabilities
$145.87M
Debt
$75.34M
Equity
$22.74M
Working capital
$18.97M
Debt to equity
3.31
Current ratio
1.27
Quick ratio
0.97
Net debt/EBITDA
-0.66
Margins
Efficiency
Dividend
EBITDA margin
-43.1%
Gross margin
63.8%
Net margin
-79.8%
Operating margin
-191.4%
Return on assets
-38.4%
Return on equity
-263.6%
Return on invested capital
-58%
Return on capital employed
-44.2%
Return on sales
-55.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
FBIO stock price
How has the Fortress Biotech stock price performed over time
Intraday
4.55%
1 week
-4.17%
1 month
2.55%
1 year
-16.58%
YTD
-20.49%
QTD
3.21%
Financial performance
How have Fortress Biotech's revenue and profit performed over time
Revenue
$57.68M
Gross profit
$36.8M
Operating income
-$110.38M
Net income
-$46M
Gross margin
63.8%
Net margin
-79.8%
The gross profit has declined by 40% year-on-year and by 12% since the previous quarter
FBIO's revenue is down by 32% year-on-year and by 8% since the previous quarter
FBIO's net income is up by 24% YoY and by 5% QoQ
FBIO's operating income is up by 22% YoY but it is down by 4.1% from the previous quarter
Growth
What is Fortress Biotech's growth rate over time
Valuation
What is Fortress Biotech stock price valuation
P/E
N/A
P/B
1.95
P/S
0.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.11
Fortress Biotech's EPS has surged by 68% YoY and by 12% QoQ
The P/B is 22% less than the 5-year quarterly average of 2.4
The company's equity rose by 7% QoQ
The P/S is 76% below the 5-year quarterly average of 2.3 but 10% above the last 4 quarters average of 0.5
FBIO's revenue is down by 32% year-on-year and by 8% since the previous quarter
Efficiency
How efficient is Fortress Biotech business performance
FBIO's return on invested capital is up by 39% year-on-year and by 5% since the previous quarter
The company's return on equity rose by 8% YoY and by 2.9% QoQ
The ROA has declined by 7% year-on-year
Fortress Biotech's return on sales has decreased by 5% YoY
Dividends
What is FBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for FBIO.
Financial health
How did Fortress Biotech financials performed over time
FBIO's quick ratio is down by 16% YoY and by 4.9% QoQ
The total assets has contracted by 14% YoY but it has grown by 13% from the previous quarter
The debt to equity has declined by 13% year-on-year
The debt has decreased by 12% YoY but it has increased by 7% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.